Novamind included as fast entry addition to the North American Psychedelics Index, the underlying index of the Horizons Psychedelic Stock Index ETF TORONTO, ON / ACCESSWIRE / February 22, 2021 / Novamind Inc. (CSE:NM | OTC PINK:NVMDF) (“Novamind” or “the Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has been selected to be included…

Source

Previous articleBright Minds Biosciences Inc. Announces Marketed Public Offering
Next articlePharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic Pharmaceuticals